Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Pegylated liposomal doxorubicin|DRUG: Docetaxel
Sponsor: ARCAGY/ GINECO GROUP